CRISPR Therapeutics AG

Healthcare · Biotechnology · Switzerland

Last price 54.26 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.25B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company’s CRISPR/Cas9 is a technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR T cell therapies, in vivo, and type 1 diabetes, as well as deve...